The Trump administration’s interest in psychedelics as medicine has continued to come into focus over the past several weeks, with two developments suggesting that momentum at the federal level continues to grow. Both President Trump and Secretary of Health and Human Services Robert F. Kennedy Jr. continue to take actions signaling their support for the
Here at Budding Trends, we like to roll up our “Top 10 Weed Roundup” between the sacred and renowned 420 holidays. Each year, we pack a recap post with 10 highly read blog posts since the previous 420 to see what’s shakin’ on shakedown street over the last year — and we have seen
As the frozen precipitation is continuing to thaw across the upper part of Mississippi, the Mississippi legislature continues to forge ahead in this year’s legislative session. If you tuned into the webinar we hosted on January 14, you heard our Mississippi government affairs colleague, Spencer Ritchie, discuss the cannabis-related legislation he expected to see this
It’s that time of year again. Our annual round-up featuring some of the most read content on Budding Trends in the past year. This year’s edition has a little something for everyone: marijuana, hemp, mushrooms, state law, federal law, banking, intellectual property, and more!
Before we dive right in, we want to plug our January
On August 11, 2025, the U.S. Drug Enforcement Administration officially transmitted a request to the Department of Health and Human Services to loosen the federal restriction on psilocybin, seeking to move one of the better-known psychedelics from Schedule I to Schedule II under the Controlled Substances Act. The petition was submitted by a familiar
Mississippi is no stranger to criticism or being the butt of jokes alleging its inability or refusal to adapt with the times. And, while some of these stereotypes have some support, Mississippi is quietly silencing some of its critics by becoming a pioneer in the plant-based medicine realm.
Beginning in 1968, Mississippi claimed host to
Drugs are bad, m’kay. But what if they’re not? Psilocybin continues to be in the limelight for its potential medicinal uses, including most particularly its potential to combat the nation’s growing mental health crisis. Last week, we reported on the fact that President Trump’s surgeon general nominee was a potential proponent of the use
Earlier this month, President Trump tapped “physician-turned wellness influencer” Casey Means as his nominee for surgeon general. Means has close ties to Health and Human Services Secretary Robert F. Kennedy Jr., and Trump has touted her “impeccable” Make America Health Again (MAHA) credentials. We’ve written previously on what impact Trump’s second presidency could
As the hallowed cannabis holiday for stoners-turned-business-entrepreneurs falls upon us, we find ourselves in the shifting sands of change in the cannabis industry as usual. Not surprisingly, many states have seen legislation brought to the table, decisions made at the courts, and commentary presented by politicians that will directly impact cannabis businesses, medical marijuana dispensaries
It’s funny how things work out – sometimes you find yourself living in a sort of butterfly effect where the tail seems to wag the dog. In 2023, when we first started writing about the traction psychedelics were gaining as medicine, our goal was not to end up spending years covering the winding legal battle